ATG

A Study of TCD601 in de Novo Renal Transplant Recipients

A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation

Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes

Autologous Stem Cell Transplantation for Crohn's Disease

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

ATG Plus Low-dose PT-Cy for GVHD Prevention

Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease

A Dose Escalation Study in de Novo Renal Transplantation

GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG

Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors

Minimal Islet Transplant at Diabetes Onset

Allo HSCT Using RIC for Hematological Diseases

The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation

Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor

M-PTCy vs BuCy in Haploidentical HSCT for Acute Leukemia

Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation

Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation

GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCT